SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T, Wu H, Liu S, Lei Z, Qin Z, Wen L, Liu K, Wang X, Guo Y, Liu Q, Liu L, Wang J, Lin L, Mao C, Zhu X, Xiao H, Bian X, Chen D, Xu C, Wang B.
Wang T, et al.
Cancer Lett. 2018 Aug 28;430:11-24. doi: 10.1016/j.canlet.2018.05.003. Epub 2018 May 8.
Cancer Lett. 2018.
PMID: 29746925